Surgery, Gastroenterology and Oncology
Vol. 23, No. 4, Aug 2018
Surgical Strategies for the Management of Perihilar Cholangiocarcinoma
Mohamed Abdel Wahab, Ahmed Shehta, Mahmoud Ali
REVIEW, Aug 2018
Article DOI: 10.21614/sgo-23-4-230
Cholangiocarcinoma is a fatal cancer arising from the biliary endothelium. Perihilar cholangiocarcinoma (pCCA) is the most common variant of cholangiocarcinoma, with increasing incidence worldwide.
Most pCCA patients present with unresectable disease at the time of diagnosis, and many patients are found to be unresectable after surgical exploration. pCCA carries a poor prognosis as more than 65% of the patients are presented with non-resectable disease at the time of diagnosis, and about 10% to 45% of patients are found to be unresectable after surgical exploration.
Surgical resection is the main stay of treatment of pCCA. The close anatomic relationship of pCCA to major hepatic vascular structures with subsequent frequent vascular invasion makes surgical resection one of the most challenging surgical procedures. To achieve a radical resection for pCCA, resection should involve resection of involved intraand extrahepatic biliary tree with safety margin, resection of related hemi-liver according to the tumor extension, caudate lobectomy, lymphadenectomy including loco-regional lymph nodes and biliary tract reconstruction through biliary-enteric anastomoses.

Despite the modern major advancements in surgical techniques and multidisciplinary management over the past years, surgical resection remains associated with high perioperative morbidities and poor survival outcomes. This aim of this review is to address the recent advances in surgical treatment for pCCA and its impact on patientsâ?? survival.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 2618


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Sept 2024

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/